Insider Trading - Kewalramani Reshma

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Kewalramani Reshma
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2021-08-19
Purchase		 2021-08-23
08:30 am		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 10,000 $195.65 $1,956,492 73,754
(Direct)		 View
2020-08-06
Sale		 2020-08-10
4:19 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,073 $271.2 $562,205 45,326
(Direct)		 View
2020-05-15
Sale		 2020-05-19
4:35 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 99 $284.17 $28,132 26,626
(Direct)		 View
2020-05-06
Sale		 2020-05-08
4:19 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,074 $272.85 $565,882 47,399
(Direct)		 View
2020-02-24
Sale		 2020-02-26
4:32 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 3,634 $233.45 $848,371 26,626
(Direct)		 View
2020-02-17
Sale		 2020-02-19
4:33 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 1,183 $243.51 $288,070 33,158
(Direct)		 View
2020-02-05
Sale		 2020-02-07
4:14 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 2,074 $239.44 $496,600 58,132
(Direct)		 View
2019-11-25
Sale		 2019-11-26
4:12 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 4,692 $219.37 $1,029,284 33,432
(Direct)		 View
2019-11-15
Sale		 2019-11-19
4:11 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 61 $205.95 $12,563 13,098
(Direct)		 View
2019-11-08
Sale		 2019-11-13
4:08 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 509 $199 $101,291 17,685
(Direct)		 View
2019-10-30
Sale		 2019-10-31
4:36 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 3,057 $199 $608,343 18,194
(Direct)		 View
2019-10-22
Sale		 2019-10-24
7:18 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 638 $189 $120,582 13,098
(Direct)		 View
2019-05-15
Sale		 2019-05-17
4:21 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 241 $165.41 $39,864 13,736
(Direct)		 View
2019-02-19
Sale		 2019-02-21
4:22 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 1,488 $186.94 $278,163 13,736
(Direct)		 View
2018-10-08
Sale		 2018-10-09
4:50 pm		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 2,305 $186.95 $430,920 1,909
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2021-11-19
Option Award		 2021-11-23
5:00 pm		 N/A
N/A		 Ginkgo Bioworks Holdings Inc. DNA Kewalramani Reshma
Director		 9,818 $0 9,818
(Direct)		 View
2021-09-16
Option Award		 2021-09-20
9:51 pm		 N/A
2031-09-15		 Ginkgo Bioworks Holdings Inc. DNA Kewalramani Reshma
Director		 69,431 $0 69,431
(Direct)		 View
2021-02-24
Tax Withholding		 2021-02-26
4:15 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,898 $217.57 63,643
(Direct)		 View
2021-02-17
Tax Withholding		 2021-02-19
4:12 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,080 $211.75 66,541
(Direct)		 View
2021-02-10
Tax Withholding		 2021-02-12
4:07 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,962 $214.16 68,621
(Direct)		 View
2021-02-03
Option Award		 2021-02-05
4:48 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 44,935 $0 71,583
(Direct)		 View
2020-08-06
Exercise		 2020-08-10
4:19 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 509 $155.57 45,326
(Direct)		 View
2020-08-06
Exercise		 2020-08-10
4:19 pm		 N/A
2029-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,073 $0 45,326
(Direct)		 View
2020-08-06
Exercise		 2020-08-10
4:19 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 1,564 $187.53 45,326
(Direct)		 View
2020-05-06
Exercise		 2020-05-08
4:19 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 510 $155.57 47,399
(Direct)		 View
2020-05-06
Exercise		 2020-05-08
4:19 pm		 N/A
2029-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 2,074 $0 47,399
(Direct)		 View
2020-05-06
Exercise		 2020-05-08
4:19 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
CEO		 1,564 $187.53 47,399
(Direct)		 View
2020-02-24
Tax Withholding		 2020-02-26
4:32 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 2,898 $239.23 26,626
(Direct)		 View
2020-02-17
Tax Withholding		 2020-02-19
4:33 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 944 $241.5 33,158
(Direct)		 View
2020-02-05
Exercise		 2020-02-07
4:14 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 510 $155.57 58,132
(Direct)		 View
2020-02-05
Exercise		 2020-02-07
4:14 pm		 N/A
2029-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 2,074 $0 58,132
(Direct)		 View
2020-02-05
Exercise		 2020-02-07
4:14 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 1,564 $187.53 58,132
(Direct)		 View
2020-02-05
Option Award		 2020-02-07
4:14 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 22,187 $0 58,132
(Direct)		 View
2019-11-25
Exercise		 2019-11-26
4:12 pm		 N/A
2029-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 4,692 $0 33,432
(Direct)		 View
2019-11-25
Exercise		 2019-11-26
4:12 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 4,692 $187.53 33,432
(Direct)		 View
2019-11-08
Exercise		 2019-11-13
4:08 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 509 $155.57 17,685
(Direct)		 View
2019-11-08
Exercise		 2019-11-13
4:08 pm		 N/A
2028-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 509 $0 17,685
(Direct)		 View
2019-10-30
Exercise		 2019-10-31
4:36 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 3,057 $155.57 18,194
(Direct)		 View
2019-10-30
Exercise		 2019-10-31
4:36 pm		 N/A
2028-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 3,057 $0 18,194
(Direct)		 View
2019-02-06
Option Award		 2019-02-08
4:39 pm		 N/A
2029-02-05		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 38,341 $0 40,250
(Direct)		 View
2018-04-01(A)
Ownership		 2018-04-02
6:46 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 0 $0 12,367
(Direct)		 View
2018-04-01
Ownership		 2018-04-02
5:25 pm		 N/A
N/A		 VERTEX PHARMACEUTICALS INC VRTX Kewalramani Reshma
EVP and CMO		 0 $0 12,367
(Direct)		 View
(A) Indicate amendment filing.